Cargando…
Interacting hepatic PAI-1/tPA gene regulatory pathways influence impaired fibrinolysis severity in obesity
Fibrinolysis is initiated by tissue-type plasminogen activator (tPA) and inhibited by plasminogen activator inhibitor 1 (PAI-1). In obese humans, plasma PAI-1 and tPA proteins are increased, but PAI-1 dominates, leading to reduced fibrinolysis and thrombosis. To understand tPA–PAI-1 regulation in ob...
Autores principales: | Zheng, Ze, Nakamura, Keiko, Gershbaum, Shana, Wang, Xiaobo, Thomas, Sherry, Bessler, Marc, Schrope, Beth, Krikhely, Abraham, Liu, Rui-Ming, Ozcan, Lale, López, José A., Tabas, Ira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7410057/ https://www.ncbi.nlm.nih.gov/pubmed/32657780 http://dx.doi.org/10.1172/JCI135919 |
Ejemplares similares
-
Expression of uPA, tPA, and PAI-1 in Calcified Aortic Valves
por: Kochtebane, Najlah, et al.
Publicado: (2014) -
Accelerated Fibrinolysis and Its Propagation on Vascular Endothelial Cells by Secreted and Retained tPA
por: Urano, Tetsumei, et al.
Publicado: (2012) -
COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography
por: Maier, Cheryl L., et al.
Publicado: (2021) -
Effect of Fagonia arabica on thrombin induced release of t-PA and complex of PAI-1 tPA in cultured HUVE cells
por: Aloni, Prutha D., et al.
Publicado: (2015) -
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022)